Prospective cross-over comparisons of three low-density lipoprotein (LDL)-apheresis methods in patients with familial hypercholesterolaemia

European Journal of Clinical Investigation

Volumn 26, Issue 11, 1996, Pages 1033-1038

  Schaumann, D ^a   Welch Wichary, M ^a   Voss, A ^a   Schmidt, H ^a   Olbricht, C J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biocompatibility; Cross over comparison; Effectiveness; LDL apheresis; Selectivity

Indexed keywords

DEXTRAN SULFATE; HEPARIN; LOW DENSITY LIPOPROTEIN;

ADSORPTION; APHERESIS; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; PRECIPITATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TECHNIQUE;

EID: 0029961935     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.2320587.x     Document Type: Article

References (21)

1. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metablic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989:672-712.
2. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous hypercholesterolaemia treated with plasma exchange. Br Med J 1985;291:1671-3.
3. Tatami R, Inoue N, Kishino B et al. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992;95:1-13.
4. Schuff-Werner P, Gohlke H, Bartmann U et al. The HELP-LDL-Apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994;24:724-32.
5. Kaplan AA, Halley SE. Plasma exchange with a rotating filter. Kidney Internat 1990;38:160-6.
6. Eisenhauer T, Armstrong VW, Wieland H, Fuchs C, Scheler F, Seidel D. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr 1987;65:161-8.
7. Seidel D, Armstrong VW, Schuff-Werner P, Group HELP. The Help-LDL-apheresis multicenter study, and angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evalution of safety and cholesterol-lowering effects during the first 12 months. Eur J Clin Invest 1991;21:375-83.
8. Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W. Treatment of familial hypercholeserolemia by means of specific immunoadsorption. J Clin Apheresis 1988;4:59-65.
9. Schulzeck P, Olbricht CJ, Koch KM. Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption. Clin Invest 1992;70:99-104.
10. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983;24:904-9.
11. Oppermann M, Schulze M, Goetze O. A sensitive immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope. Complement Inflamm 1991;8:13-24.
12. Haubitz M, Schulze M, Koch KM. Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transplant 1990;5:500-3.
13. Kojima S, Shiba M, Nomura S et al. Evaluation of albumin loss during low-density lipoprotein apheresis. Trans Am Soc Artif Intern Organs 1990;26:830-3.
14. Schuff-Werner P, Schütz E, Reitemeyer F et al. eds. Heparin-induced extracorporeal LDL precipitation (HELP): Rheological, hemostasiological and immunological effects. Basel: Karger, 1990:196-204. (Gotto AM, Mancini M, Richter WO, eds. Treatment of severe hypercholesterolemia in the prevention of coronary heart disease: vol. 2).
15. Yamamoto A, Kojima S, Shiba-Harada M, Kawaguchi A, Hatanaka K. Assessment of the biocompatibility and long-term effect of LDL-apheresis by dextran sulfate-cellulose column. Artificial Organs 1992;16:177-81.
16. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Internat 1983;24:764-9.
17. Würzner R, Schuff-Werner P, Franzke A et al. Complement activation and depletion duringd LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP). Eur J Clin Invest 1991;21:288-94.
18. Hörl WH, Feinstein EI, Wanner C, Frischmuth N, Gösele A, Massry SG. Plasma levels of main granulocyte components during hemodialysis: Comparison of new and reused dialyzers. Am J Nephrol 1990;10:53-7.
19. Böhler J, Donauer K, Köster W, Schollmeyer PJ, Wieland H, Horl WH. Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia. Am J Nephrol 1991;11:479-85.
20. Kojima A, Harada-Shiba M, Nomura S et al. Effect of nafamostat mesilate on bradykinine generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column. Trans Am Soc Artif Intern Organs 1991;37:644-8.
21. Olbricht CJ, Schaumann D, Fischer D. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors. Lancet 1992;340:908-9.